Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

CROHN'S & COLITIS FOUNDATION

Filed by FAEGRE DRINKER BIDDLE & REATH LLP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-10-28 06:26:13 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2026
Income
$30,000.00
Expenses
Not reported
Filing UUID
c876d9c8-d4fa-4595-8e5d-d2d14d94ac53
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

FY 26 and FY 27 inflammatory bowel disease (IBD) research, public health and therapy development policy priorities.

HCR · Health Issues

Nutrition issues pertaining to Make America Healthy Again agenda and the Office of Nutrition Research strategic plan; Safe Step Act (H.R. 5509/S.2903); Congressional Crohn's & Colitis Caucus; Issues pertaining to the FDA review of therapies to treat pediatric IBD.

Literal federal measure citations: H.R. 5509, S.2903

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.